Skip to main content
TEM
NASDAQ Technology

Tempus AI Reports Mixed Q1 2026 Results with Widened Net Loss and Significant CEO Selling Plan

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Health Tech Stocks · Healthcare
Sentiment info
Neutral
Importance info
8
Price
$50.42
Mkt Cap
$9.7B
52W Low
$41.73
52W High
$104.32
52W Position info
21% above low
Off High info
52% below high
Rel. Volume info
1.1× avg
Market data snapshot near publication time

TEM sits 21% above its 52-week low of $41.73.

Summary

Tempus AI reported strong 36.1% revenue growth and improved Adjusted EBITDA in Q1 2026, but net losses widened significantly. The company also disclosed a substantial Rule 10b5-1 selling plan by CEO Eric Lefkofsky.


Key Events · Earnings and Guidance · TEM

  • Strong Revenue Growth

    Total net revenue increased 36.1% year-over-year to $348.1 million in Q1 2026, driven by both Diagnostics and Data & Applications segments.

  • Widened Net Loss

    Net loss significantly widened to $125.9 million in Q1 2026, an 85.1% increase from $68.0 million in Q1 2025, primarily due to non-recurring tax benefits in the prior year and higher stock-based compensation.

  • Improved Operational Performance

    Adjusted EBITDA showed significant improvement, narrowing to a loss of $2.8 million in Q1 2026 from a loss of $16.2 million in Q1 2025.

  • Solid Liquidity Position

    The company reported $525.9 million in cash and equivalents as of March 31, 2026, projecting sufficient liquidity to fund operations for over 12 months.


Analysis · TEM · Technology

Tempus AI's Q1 2026 results present a mixed financial picture. While the company achieved robust revenue growth of 36.1% year-over-year, demonstrating continued demand for its diagnostics and data solutions, the net loss widened considerably. This increase in net loss is largely attributable to the absence of a significant non-recurring tax benefit recognized in Q1 2025 and a substantial rise in stock-based compensation expenses. Positively, the company's Adjusted EBITDA improved significantly, suggesting better underlying operational efficiency. Furthermore, Tempus AI affirmed a solid liquidity position, with sufficient cash and equivalents to cover its operating plan for more than a year. However, the disclosure of CEO Eric Lefkofsky's adoption of a Rule 10b5-1 plan to sell a substantial amount of shares (approximately $355.5 million) through controlled entities introduces a notable negative signal, indicating a significant planned distribution by a key insider. Investors will likely weigh the strong revenue growth and improved operational metrics against the widening net loss and the large insider selling plan.

At the time of this filing, TEM was trading at $50.42 on NASDAQ in the Technology sector, with a market capitalization of approximately $9.7B. The 52-week trading range was $41.73 to $104.32. This filing was assessed with neutral market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

TEM - Latest Insights

TEM
Aug 04, 2026, 8:30 AM EDT
Source: BusinessWire
Importance Score:
7
Price at Filing: $46.50
Real-time Price: $46.78 info
Change: +$0.2799 (+0.60%) info
Market Cap: $8.322B info
TEM
Aug 03, 2026, 7:33 AM EDT
Source: Wiseek News
Importance Score:
8
Price at Filing: $44.05
Real-time Price: $46.78 info
Change: +$2.73 (+6%) info
Market Cap: $8.322B info
TEM
Jul 30, 2026, 5:06 PM EDT
Source: Benzinga
Importance Score:
8
Price at Filing: $43.63
Real-time Price: $46.78 info
Change: +$3.15 (+7%) info
Market Cap: $8.322B info
TEM
Jul 30, 2026, 4:03 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $43.25
Real-time Price: $46.78 info
Change: +$3.53 (+8%) info
Market Cap: $8.322B info
TEM
Jul 30, 2026, 4:01 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $44.29
Real-time Price: $46.78 info
Change: +$2.49 (+6%) info
Market Cap: $8.322B info